161 related articles for article (PubMed ID: 8387455)
21. Production and characterization of an Mls-1-specific monoclonal antibody.
Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
[TBL] [Abstract][Full Text] [Related]
22. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire.
Kilgannon P; Novak Z; Fotedar A; Singh B
Mol Immunol; 2010 Feb; 47(5):1154-60. PubMed ID: 19954850
[TBL] [Abstract][Full Text] [Related]
23. Physiologic expression of two superantigens in the BDF1 mouse.
Gollob KJ; Palmer E
J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
[TBL] [Abstract][Full Text] [Related]
24. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.
Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381
[TBL] [Abstract][Full Text] [Related]
25. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
McMahon CW; Bogatzki LY; Pullen AM
Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
[TBL] [Abstract][Full Text] [Related]
26. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
27. Negative segregation of Mtv loci in H-2E+ mice selected for high antibody response.
Roger T; Boudaly S; Seman M
Immunogenetics; 1994; 40(2):123-8. PubMed ID: 8026861
[TBL] [Abstract][Full Text] [Related]
28. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
[TBL] [Abstract][Full Text] [Related]
29. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
Pullen AM; Bogatzki LY
J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
[TBL] [Abstract][Full Text] [Related]
30. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
32. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens.
Pullen AM; Choi Y; Kushnir E; Kappler J; Marrack P
J Exp Med; 1992 Jan; 175(1):41-7. PubMed ID: 1309854
[TBL] [Abstract][Full Text] [Related]
33. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.
Golovkina TV; Piazzon I; Nepomnaschy I; Buggiano V; de Olano Vela M; Ross SR
J Virol; 1997 May; 71(5):3895-903. PubMed ID: 9094666
[TBL] [Abstract][Full Text] [Related]
34. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.
Wirth S; Vessaz A; Krummenacher C; Baribaud F; Acha-Orbea H; Diggelmann H
J Virol; 2002 Nov; 76(21):11172-5. PubMed ID: 12368363
[TBL] [Abstract][Full Text] [Related]
35. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
36. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
38. Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes.
Matsuzawa A; Yasuda T; Sakamoto S; Nagase H; Nakano H; Yoshimoto T
Scand J Immunol; 2001 Jun; 53(6):553-62. PubMed ID: 11422903
[TBL] [Abstract][Full Text] [Related]
39. Efficient presentation of endogenous superantigen by H-2Aq.
Dyson PJ; Elliott J; Antoniou AN; Corley KT
Eur J Immunol; 1998 Mar; 28(3):1034-9. PubMed ID: 9541599
[TBL] [Abstract][Full Text] [Related]
40. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
